Thursday, September 30, 2021 10:39:03 AM
Regarding children, did you see the undercover video of the J&J exec and scientist, and what they *really* think about the J&J Covid vaccine and giving them to kids?
https://www.projectveritas.com/news/johnson-and-johnson-children-dont-need-the-f-cking-covid-vaccine-because/
I'm sad for all our kids having to deal with so much BS from adults, and wish they could just be kids and not have to worry about all this other stuff. Seeing kids playing baseball outside wearing masks everywhere (even the adults sitting 10 feet apart from each other in the fresh air) last year was surreal. Hard to know what is right for the kids sometimes. Hopefully they are resilient! Will they ever have a "normal" again (Covid/masks/vaccines, gender/race/orientation and other politics in school), or will the adults keep throwing their agenda at them? So much emphasis on safety for them, which is good, but it really can go too far sometimes. There is no perfect safety in our world. Zero Covid is impossible with mandates.
It will be great to have some decent Covid treatment options. I still think nucleotide encoded MABs given as a single IM/ID shot early in disease or even prophylactic on exposure or high risk are the way to go. DoD is funding some such work. Will see how some of these oral antivirals work before long too.
Yes, therapeutics should be a high priority, but sadly for poorly capitalized biotechs like us, we can't get much help. Hopefully the academics (Dr. Narayanan lab at GMU, others promised too) are able to get some grants for basic research, and perhaps we have someone in a clinical position kind enough to apply for money to run a trial. More likely that would be BP partner and/or government for Phase 3 if we show some promise in our Phase 2 trial.
Can't believe it will take so long to get our brilacidin Phase 2 results together, but I guess there are a lot of data and endpoints to check and analyze. What are we expecting - another 4-8 weeks now for our results, or 2-3 months after final 60 day endpoint?
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM